SCHEMBL8418927

SCHEMBL8418927

CCN(CC)C(=O)/C=C(\C)c1ccc(OCCc2ccccc2)c(OCC(=O)O)c1

nearest known ligand 0.81

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
LTB4R Q15722 20/20 0.81
LTB4R2 Q9NPC1 20/20 0.81

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8573084 1.00 LTB4R (0.81) LTB4RLTB4R2
SCHEMBL8420323 1.00 LTB4R (0.81) LTB4RLTB4R2
SCHEMBL8420120 0.92 LTB4R (0.71) LTB4RLTB4R2
SCHEMBL7993668 0.90 LTB4R (1.00) LTB4RLTB4R2
SCHEMBL7993662 0.90 LTB4R (1.00) LTB4RLTB4R2
SCHEMBL7993672 0.90 LTB4R (1.00) LTB4RLTB4R2
SCHEMBL8418435 0.88 LTB4R (0.83) LTB4RLTB4R2
SCHEMBL7988234 0.87 LTB4R (1.00) LTB4RLTB4R2
SCHEMBL7988242 0.87 LTB4R (1.00) LTB4RLTB4R2
SCHEMBL7988237 0.87 LTB4R (1.00) LTB4RLTB4R2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0942903-A1 ARYL-SUBSTITUTED ACRYLAMIDES WITH LEUKOTRIENE B4 (LTB-4) RECEPTOR ANTAGONIST ACTIVITY Novartis AG (CH) 1999-09-22 EP disclosed
WO-1998013347-A1 ARYL-SUBSTITUTED ACRYLAMIDES WITH LEUKOTRIENE B4 (LTB-4) RECEPTOR ANTAGONIST ACTIVITY NOVARTIS AG (CH) 1998-04-02 WO disclosed